Empire Genomics

Empire Genomics is a leading company in the field of molecular diagnostics, specializing in the development, manufacturing, and distribution of molecular biomarkers. Here are some key aspects of what they offer:

• FISH Probes: These are used in fluorescence in situ hybridization (FISH) to detect specific genes or chromosomal regions in DNA samples. They offer various types of probes, including control, copy number variation, break apart, and fusion probes.

• Biomarkers: Empire Genomics provides over one million biomarkers for various diagnostic and research purposes.

• Custom Solutions: They work with clinical and research institutions to develop diagnostic tests that can quickly bring new drugs targeting specific gene mutations to market.

• Acquisition: Recently, Empire Genomics was acquired by BioCare Medical, which has expanded their portfolio and capabilities in molecular diagnostics.